Physician profile
Kenneth Chi Chow
NPI 1649760984
$1,413.60
in general payments reported to CMS, 2019-2025
10 companies · $19.07 in 2025
The $19.07 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $202 · 2022: $1,008 · 2023: $73.30 · 2025: $19.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $92.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $92.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $568.74 | 2021-2023 | Wegovy |
| Glaxosmithkline, LLC. | $399.43 | 2020-2023 | Shingrix, Bexsero |
| Lilly USA, LLC | $131.77 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.96 | 2022 | |
| Gilead Sciences, INC. | $93.20 | 2022 | |
| Pfizer INC. | $24.36 | 2021 | |
| Myovant Sciences INC. | $22.18 | 2021 | |
| Abbott Laboratories | $19.51 | 2020 | |
| Edwards Lifesciences Corporation | $19.07 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Hologic Sales and Service, LLC | $15.38 | 2023 | Thinprep 2000 Processor, Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.